Idiopathic Hypersomnia-A Dynamic Simulation Model.

dynamic modeling idiopathic hypersomnia sleep disorders treatment strategy work impairment

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2022
Historique:
received: 23 03 2022
accepted: 02 05 2022
entrez: 27 6 2022
pubmed: 28 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

Commonly used approach to illness assessment focuses on the patient's actual state supplemented by binary records of past events and conditions. This research project was designed to explain subjective experience in idiopathic hypersomnia (IH) patients influenced by their clinical symptoms and comorbidities. Forty-three IH patients of both sexes (female 60.5%, male 39.5%) were assessed using a detailed structured examination. The interview covered neurologic, psychiatric, and internal medicine anamnesis, medication past and current, substance abuse, work impairment, detailed sleep-related data, specific sleep medication, and a full-length set of questionnaires including depression, quality of life, sleepiness, anxiety, fatigue, insomnia, and sleep inertia. The data were digitized and imported into statistical software (SPSS by IBM), and dynamic simulation software (Vensim by Ventana Systems Inc.) was used to build a causal loop diagram and stocks and flows diagram as a simulation structure. The overall raw data and simulation-based patterns fit at 76.1%. The simulation results also identified the parameters that contribute the most to patients' subjective experience. These included sleep inertia, the refreshing potential of naps, the quality of nocturnal sleep, and the social aspects of the patient's life. Psychiatric disorders influence the overall pattern at a surprisingly low level. The influence of medication has been studied in detail. Although its contribution to the dynamics looks marginal at first sight, it significantly influences the contribution of other variables to the overall patient experience of the disease. Even the simplified dynamic structure designed by the research team reflects the real-life events in patients with IH at the acceptable level of 76.1% and suggests that a similar structure plays an important role in the course of the disease. Therapeutic focus on the parameters identified by the model should enhance the patients' subjective experience throughout illness duration and might even turn the progress from negative into positive. Further research is needed to understand the dynamics of idiopathic hypersomnia in greater detail to better understand the causes and design therapeutic approaches to improve patients' quality of life.

Identifiants

pubmed: 35756941
doi: 10.3389/fneur.2022.902637
pmc: PMC9226714
doi:

Types de publication

Journal Article

Langues

eng

Pagination

902637

Informations de copyright

Copyright © 2022 Susta, Šonka, Bizik, Petranek and Nevsimalova.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Sci Sleep. 2022 Feb 26;14:311-322
pubmed: 35450222
Sleep Med Clin. 2017 Mar;12(1):xv
pubmed: 28159102
J Clin Psychol. 1999 Jan;55(1):117-28
pubmed: 10100838
Sleep Med. 2015 Feb;16(2):225-31
pubmed: 25576137
Sleep. 2022 Jan 11;45(1):
pubmed: 34436617
J Clin Sleep Med. 2021 Nov 1;17(11):2249-2256
pubmed: 34032202
Hum Factors. 2019 Nov;61(7):1099-1111
pubmed: 30908091
J Head Trauma Rehabil. 2015 Jul-Aug;30(4):277-82
pubmed: 24721811
Front Physiol. 2021 Jan 13;11:612787
pubmed: 33519518
Neuro Endocrinol Lett. 2015;36(8):758-66
pubmed: 26921576
Sleep Med. 2021 Apr;80:86-91
pubmed: 33588261
Sleep Breath. 2020 Jun;24(2):413-424
pubmed: 31444679
Sleep Breath. 2020 Dec;24(4):1759-1765
pubmed: 31938991
J Sleep Res. 2017 Feb;26(1):30-37
pubmed: 27523905
Neurology. 2019 Apr 9;92(15):e1754-e1762
pubmed: 30867266
Prim Care Companion CNS Disord. 2020 Feb 20;22(1):
pubmed: 32083819
Sleep Med Clin. 2017 Sep;12(3):331-344
pubmed: 28778232
Sleep. 2021 Oct 11;44(10):
pubmed: 33991415
Sleep Med Rev. 2001 Oct;5(5):349-358
pubmed: 12530998
J Thorac Dis. 2018 Jan;10(Suppl 1):S170-S176
pubmed: 29445541
Ann Neurol. 2016 Aug;80(2):259-68
pubmed: 27315195
J Clin Sleep Med. 2021 Sep 1;17(9):1881-1893
pubmed: 34743789
Sleep Med Rev. 2016 Oct;29:23-33
pubmed: 26599679
J Pers Assess. 1996 Dec;67(3):588-97
pubmed: 8991972
Sleep. 2021 Aug 13;44(8):
pubmed: 33693888
Ther Adv Neurol Disord. 2012 Sep;5(5):297-305
pubmed: 22973425
Prague Med Rep. 2021;122(3):127-139
pubmed: 34606428
Aust Health Rev. 2016 Jun;40(3):235-243
pubmed: 26456551
Braz J Med Biol Res. 2006 Jul;39(7):863-71
pubmed: 16862276
Psychogeriatrics. 2016 May;16(3):196-201
pubmed: 26179318
Psychosomatics. 2016 Mar-Apr;57(2):152-64
pubmed: 26895727
Cesk Neurol. 1956 Mar;19(1):48-58
pubmed: 13343296
Sleep Med. 2020 Nov;75:256-262
pubmed: 32862014

Auteurs

Marek Susta (M)

Department of Public Health, St. Elisabeth University, Bratislava, Slovakia.

Karel Šonka (K)

Department of Neurology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czechia.

Gustav Bizik (G)

Department of Psychiatry, Aalborg University, Aalborg, Denmark.

Svojmil Petranek (S)

Health Care Facility, Department of the Interior, Prague, Czechia.

Sona Nevsimalova (S)

Department of Neurology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czechia.

Classifications MeSH